Eczema primary prevention: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Primary prevention]] is the most effective means to avoid [[complications]] of eczema. [[Emolients]] and consumption of [[prebiotics]] and [[probiotics]] can prevent the occurrence of this condition. <ref name="pmid1926547">{{cite journal| author=Macharia WM, Anabwani GM, Owili DM| title=Effects of skin contactants on evolution of atopic dermatitis in child[[Primary prevention]] is the most effective means to avoid [[complications]] of eczema. This can be achieved by applying [[emolients]] on the [[skin]], and consumption of [[probiotics]] and [[prebiotics]].ren: a case control study. | journal=Trop Doct | year= 1991 | volume= 21 | issue= 3 | pages= 104-6 | pmid=1926547 | doi=10.1177/004947559102100305 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1926547 }} </ref> <ref name="pmid22153774">{{cite journal| author=Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC| title=Low diversity of the gut microbiota in infants with atopic eczema. | journal=J Allergy Clin Immunol | year= 2012 | volume= 129 | issue= 2 | pages= 434-40, 440.e1-2 | pmid=22153774 | doi=10.1016/j.jaci.2011.10.025 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22153774 }} </ref> | [[Primary prevention]] is the most effective means to avoid [[complications]] of eczema. [[Emolients]] and consumption of [[prebiotics]] and [[probiotics]] can prevent the occurrence of this condition. <ref name="pmid1926547">{{cite journal| author=Macharia WM, Anabwani GM, Owili DM| title=Effects of skin contactants on evolution of atopic dermatitis in child[[Primary prevention]] is the most effective means to avoid [[complications]] of eczema. This can be achieved by applying [[emolients]] on the [[skin]], and consumption of [[probiotics]] and [[prebiotics]].ren: a case control study. | journal=Trop Doct | year= 1991 | volume= 21 | issue= 3 | pages= 104-6 | pmid=1926547 | doi=10.1177/004947559102100305 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1926547 }} </ref> <ref name="pmid22153774">{{cite journal| author=Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC| title=Low diversity of the gut microbiota in infants with atopic eczema. | journal=J Allergy Clin Immunol | year= 2012 | volume= 129 | issue= 2 | pages= 434-40, 440.e1-2 | pmid=22153774 | doi=10.1016/j.jaci.2011.10.025 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22153774 }} </ref> [[Exclusive breastfeeding]] in a duration of three to four months has been proven to reduce the risk of acquiring [[eczema]] in children ≤ 2 years old.<ref name="pmid30886111">{{cite journal| author=Greer FR, Sicherer SH, Burks AW, COMMITTEE ON NUTRITION. SECTION ON ALLERGY AND IMMUNOLOGY| title=The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. | journal=Pediatrics | year= 2019 | volume= 143 | issue= 4 | pages= | pmid=30886111 | doi=10.1542/peds.2019-0281 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30886111 }} </ref> | ||
==Prevention== | ==Prevention== |
Revision as of 00:05, 22 June 2022
Eczema Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Eczema On the Web |
American Roentgen Ray Society Images of Eczema |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Primary prevention is the most effective means to avoid complications of eczema. Emolients and consumption of prebiotics and probiotics can prevent the occurrence of this condition. [1] [2] Exclusive breastfeeding in a duration of three to four months has been proven to reduce the risk of acquiring eczema in children ≤ 2 years old.[3]
Prevention
- Emolients and consumption of prebiotics and probiotics can prevent the occurrence of this condition.
- Avoidance of allergens is also a helpful method. [4]
- Vitamin D supplementation can regulate the skin barrier.[5]
References
- ↑ Macharia WM, Anabwani GM, Owili DM (1991). "Effects of skin contactants on evolution of atopic dermatitis in child[[Primary prevention]] is the most effective means to avoid [[complications]] of eczema. This can be achieved by applying [[emolients]] on the [[skin]], and consumption of [[probiotics]] and [[prebiotics]].ren: a case control study". Trop Doct. 21 (3): 104–6. doi:10.1177/004947559102100305. PMID 1926547. URL–wikilink conflict (help)
- ↑ Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC (2012). "Low diversity of the gut microbiota in infants with atopic eczema". J Allergy Clin Immunol. 129 (2): 434–40, 440.e1–2. doi:10.1016/j.jaci.2011.10.025. PMID 22153774.
- ↑ Greer FR, Sicherer SH, Burks AW, COMMITTEE ON NUTRITION. SECTION ON ALLERGY AND IMMUNOLOGY (2019). "The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods". Pediatrics. 143 (4). doi:10.1542/peds.2019-0281. PMID 30886111.
- ↑ Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M; et al. (2020). "ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children". J Eur Acad Dermatol Venereol. 34 (12): 2717–2744. doi:10.1111/jdv.16892. PMID 33205485 Check
|pmid=
value (help). - ↑ Palmer DJ (2015). "Vitamin D and the Development of Atopic Eczema". J Clin Med. 4 (5): 1036–50. doi:10.3390/jcm4051036. PMC 4470215. PMID 26239464.